CFDE Data Portal | Search NF1P8

	Label	Description
	NF1P8 associations Collection (Entity type)	Associations for NF1P8_associations
	NF1P8 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NF1P8 Gene (Entity type)	ENSG00000236956 - neurofibromin 1 pseudogene 8
	GSE100148 EZH2 inhibition 10 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE153867 olaparib 6 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 prednisolone muscle organ 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172494 nicotinamide 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 matrine 1 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 lenalidomide 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

NF1P8 associations

Associations for NF1P8_associations

NF1P8 associations.tsv

A file from IDG as part of the Harmonizome project

NF1P8

ENSG00000236956 - neurofibromin 1 pseudogene 8

GSE100148 EZH2 inhibition 10 v 5 human dn

A Gene Set from LINCS

GSE153867 olaparib 6 v 4 human dn

A Gene Set from LINCS

GSE164874 prednisolone muscle organ 5 v 1 human dn

A Gene Set from LINCS

GSE172494 nicotinamide 3 v 1 human dn

A Gene Set from LINCS

GSE201309 matrine 1 v 8 human dn

A Gene Set from LINCS

GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 3 human dn

A Gene Set from LINCS

GSE76425 lenalidomide 0 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.